Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GPCR
#725
Structure Therapeutics Inc. American Depositary Shares
62.980
0
-0.54%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-0.54%
Mudança mensal
-29.15%
Mudança em 6 meses
+135.53%
Mudança anual
+135.53%
Fechamento anterior
63.325
0
Open
62.950
0
Bid
Ask
Low
62.950
0
High
62.980
0
Volume
46
Mercados
Ações
Cuidados de saúde
GPCR
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2023
2024
2025
Total assets
482.02 M
903.33 M
1.58 B
Total liabilities
29.05 M
38.49 M
67.54 M
Total equity
452.97 M
864.84 M
1.52 B
Total liabilities & shareholders' equities
482.02 M
903.33 M
1.58 B
Total debt
—
—
—
Net debt
—
—
—
Notícias
Ações da Structure Therapeutics podem subir com dados de medicamento para obesidade, diz Cantor
Structure Therapeutics shares could rise on obesity drug data, Cantor says
Citizens reduz preço-alvo da Structure Therapeutics com expansão do pipeline
Citizens cuts Structure Therapeutics stock price target on pipeline expansion
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report
Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026
Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown